Page 1576 - Small Animal Internal Medicine, 6th Edition
P. 1576

1548   Index


            Alimentary tract parasites (Continued)  Amyloidosis, 693b  Antiarrhythmic drugs (Continued)  Antiemetics, 437–438, 438t, 632–633
             strongyloidiasis, 488     glomerular, 679–680, 679f  class III, 88, 90t–91t, 95–96  chronic kidney disease, 701
             tapeworms, 487–488        hepatic, in cats, 575–576  class IV, 88, 90t–91t, 96–97. see also   Antiepileptic drugs
  VetBooks.ir  Alimentary tract perforation, 422  Anabolic steroids, 702  classification of, 88, 89t  diazepam, 1104
                                       islet, 831f
                                                                    Calcium channel blockers
                                                                                           description of, 1100–1101
             trichomoniasis, 490–491, 490f
             whipworms, 485–486, 485f
                                      Anaerobes, 1431
                                                                 dilated cardiomyopathy treated with,
                                                                                           for dogs, 1101t
            Alizine. see Aglepristone
                                                                    145
                                      Anal sac (apocrine gland)
            Alkaline phosphatase, 564–565, 861,   Anaerobic infections, 1438–1440  dosage of, 90t–91t  felbamate, 1104
                                                                                           gabapentin, 1103–1104
               880–881                  adenocarcinoma, 506      lidocaine. see Lidocaine  levetiracetam, 1103
            Alkylating agents, 1272–1273, 1273b  Anal sacculitis, 505  mechanism of action of, 88  potassium bromide, 1102–1103
            Allantoin, 719–720, 720f  Analgesia, 1268t           mexiletine, 90t–91t, 92   pregabalin, 1104
            Allergic bronchitis, 329t, 337  for acute pancreatitis, 628–631,   phenytoin, 90t–91t, 93  Antiestrogens, 959
            Allergic pneumonitis, 201     629t–630t              procainamide. see Procainamide  Antifibrotics, 593
            Allergic reactions, to insulin, 827  in cats, 227b   quinidine. see Quinidine  Antigen-specific T lymphocytes, 1451
            Allergic rhinitis, 266    Anaphylactic reactions, 1281  ventricular tachyarrhythmias treated   Antihistamines, 266
             clinical features of, 266  Anaplasma spp.              with, 84             Antihypertensive drugs
             diagnosis of, 266         A. phagocytophilum, 1128–1129, 1190f,   Antibacterial drugs, 442–443  hypertension treated with, 215, 217t
             etiology of, 266             1430f, 1432–1433, 1440t,   Antibiotic-responsive enteropathy, 399,   hypotension caused by, 218
             prognosis for, 266           1443–1444, 1469, 1470f, 1470t,   401b, 492     Antiinflammatory drugs, 441–442
             radiographic signs of, 249b  1471, 1533t–1535t    Antibiotics. see also Antimicrobial drugs  Antilentiviral drugs, 1494
             treatment of, 266         A. platys, 1440t, 1470t, 1472  abdominal sepsis treated with, 443  Antimetabolites, 1273, 1273b
            Allometric scaling, 23–25  Anasarca, 969, 1020       acute pancreatitis treated with, 633  Antimicrobial drugs, 1436. see also
            Allopurinol, 720–721      Ancef. see Cefazolin       bacterial endocarditis treated with,   Antibiotics
            Alopecia                  Ancylostoma spp., 1533t–1535t, 1536  1441            anaerobic infections treated with,
             chemotherapy-related, 1282–1283,   Anechoic, defined, 19  bacterial meningoencephalomyelitis   1438–1440
                1283f                 Anemia                        treated with, 1123     bacteremia treated with, 1440–1442
             endocrine, 747–749, 747f, 748t–749t,   aplastic, 1240  bacterial pneumonia treated with,   bacterial endocarditis treated with,
                750f                   blood loss, 1345–1346, 1346t  341–342, 341b           1440–1442
            Alopecia X, 748–749, 748t, 750f  chemotherapy-induced, 1278  bacterial rhinitis treated with, 259  central nervous system infections
            Aluminum hydroxide, 439t, 515t–517t,   of chronic disease, 1352–1353, 1352t  brucellosis treated with, 965  treated with, 1440t, 1442
               700–701                 in chronic kidney disease, 697  canine chronic bronchitis treated with,   gastrointestinal infections treated with,
            Alveolar pattern, 290–292, 291f,    clinical manifestations of, 1340–1345,   328  1440t, 1442–1443
               291b                       1341b, 1343f           canine chronic hepatitis treated with,   hepatic infections treated with,
            Alveolar-arterial gradient, 317–318, 317t,   clinicopathologic findings, 1340–1345,   593  1442–1443
               318b                       1341b, 1343f           diskospondylitis treated with, 1144  joint infections treated with, 1440t
            Amantadine, 1197t, 1209t–1210t  definition of, 1340  feline chronic rhinosinusitis treated   muscle infections treated with,
            Amastigotes, 1526          diagnostic tests for, 1218t–1219t  with, 267–268      1440t
            Ambulatory electrocardiography, 49–51  of endocrine disease, 1351–1352  feline coronavirus treated with, 1491  musculoskeletal infections with,
             Holter monitoring, 49–50  hemolytic. see Hemolytic anemia  feline upper respiratory infection   1443–1444
             intermittent event recording, 50–51  iron deficiency, 1354–1355, 1356f  treated with, 258  respiratory tract infections treated
            American trypanosomiasis, 1525–1526  in lymphadenopathy, 1414–1415  infective endocarditis treated with,   with, 1441t, 1444–1445
            Amiglyde. see Amikacin     management of, 1345–1355     136–137                skin infections treated with, 1445
            Amikacin (Amiglyde), 386t–388t,   nonregenerative, 1218t–1219t,   otitis media-interna treated with, 1113  soft tissue infections treated with,
               515t–517t, 1437t–1438t     1351–1355, 1352b, 1358f, 1426t  prophylactic use of, 348  1445
            Aminoglycosides            pathogenetic classification of, 1344b  prostatitis treated with, 1441t  toxicities, 1439t
             ototoxicity caused by, 1114–1115  regenerative, 1218t–1219t, 1342–1343,   pyometra treated with, 1441t  types of, 1437t–1438t
             toxicity caused by, 1439t    1344f, 1358f, 1426t    pyothorax treated with, 371  urogenital infections treated with,
             types of, 1437t–1438t     in splenomegaly, 1414–1415  Antibodies                1441t, 1445–1446
            Aminopentamide, 437        transfusion therapy for, 1355–1358,   to acetylcholine receptors, 424  Antinuclear antibody test, 1217
            Aminophylline, 62b, 327b, 386t–388t  1357t           detection of            Antioxidants, 590–591
            Amiodarone, 95–96         Anestrus, 937f, 938t, 949, 955,   in body fluids, 1434–1435  Antiplatelet antibodies, 1216–1218
             adverse effects of, 96     1034t–1036t               in serum, 1433–1434    Antiplatelet therapy, 227b, 228
             antiarrhythmic effects of, 95  Angiocardiography, 52  feline immunodeficiency virus, 1494  Antiprogestational agents, 960
             in dogs, 90t–91t          selective, 52             insulin-binding, 828    Antiprolactin therapy, 978
             dosage of, 90t–91t       Angiography              Anticancer drugs. see also Chemotherapy  Antiprotozoal drugs, 444t
            Amitriptyline, 716, 728b, 733t–734t  computed tomography pulmonary,   handling of, 1274  Antirobe. see Clindamycin
            Amlodipine besylate, 62b, 63, 97  356                mechanism of action, 1272  Antisecretory drugs, 441–442
             bioavailability of, 71    selective, 356            neurotoxicity caused by, 1285  Antithrombin, 684
             chronic heart failure treated with, 64t,   Angiotensin II, 56, 67  nonselective nature of, 1276  deficiency of, 223
                71                    Angiotensin receptor blockers, chronic   occupational exposure to, 1274  description of, 1388
             hypertension treated with, 215,    kidney disease, 701  pharmacokinetics of, 1276  Antithyroid drugs
                217t                  Angiotensin-converting enzyme, 56  reconstitution of, 1274  canine thyroid neoplasia treated with,
            Ammonia, and hepatic encephalopathy,   adverse effects of, 67  spills of, 1274   803–804
               523f                    aldosterone levels affected by, 67  toxicity of, 1277t–1278t  hyperthyroidism in cats treated with,
            Ammonium biurate crystals, 669f  chronic heart failure treated with, 64t,   types of, 1272–1273, 1273b  794–797
            Amoeba, 1538–1539             67–68                Anticholinergic drugs, 97  Antitumor antibiotics, 1273, 1273b
            Amoxicillin, 386t–388t, 515t–517t  dilated cardiomyopathy treated with,   cardiac effects of, 97  Antral mucosal hypertrophy, gastric, 465,
             bacterial infections treated with,   145            in cats, 90t–91t           466f
                1437t–1438t            hypertrophic cardiomyopathy treated   in dogs, 90t–91t  Anzemet. see Dolasetron
             joint disease treated with, 1209t–1210t  with, 163–164  dosage of, 90t–91t  Aortic dilation, 10–11
             neutrophilic cholangitis treated with,   Angiotensin-converting enzyme   sick sinus syndrome treated with,   Aortoiliac thrombosis, 1405
                570                     inhibitors                  86–87                Apatite-containing calculi, 721
            Amoxicillin-clavulanate, 386t–388t,   chronic heart failure treated with, 128  sinus bradycardia treated with, 86  Apex, 9
               1185t–1186t, 1209t–1210t,   chronic kidney disease treated with,   Anticholinesterase, 1171b, 1250  Aplastic anemia, idiopathic, 1240
               1437t–1438t                701                  Anticoagulants            Apolipoproteins, 908
            Amphojel. see Aluminum hydroxide  hypertension treated with, 215, 217t  arterial thromboembolism in cats   Apomorphine, 515t–517t, 1185t–1186t
            Amphotericin B, 515t–517t, 1504–1505,   Animal inoculation, 1433  treated with, 227b  Apoptosis, 1269
               1504t, 1509            Anorexia                   thromboembolism prophylaxis, 1405  Arginine vasopressin, 740
            Amphotericin B deoxycholate, 1504t  chemotherapy-related, 1281  Anticonvulsants  diabetes insipidus, 741–742, 745f
            Ampicillin, 386t–388t, 515t–517t,   description of, 407, 407b  chronic, 1101b  Arrhythmias, 130
               1209t–1210t            Antacid drugs, 438–439, 439t  oral, 1101b            approach to, 77–78
            Ampicillin sodium, 1437t–1438t  Anthelmintic drugs, 443, 444t  phenobarbital, 1101–1102  bradyarrhythmias. see
            Ampicillin-sulbactam, 386t–388t,   Antiarrhythmic drugs, 77–99  Antidiarrheals, 474  Bradyarrhythmias
               1437t–1438t             class I, 88–93, 89t     Antidiuretic hormone, 662   clinical presentation of, 79, 80b
            Amrinone, 62b              class II, 88, 90t–91t, 93–95. see also   physiologic effects of, 56  development of, 77
            Amyloid A protein, 679        β-Blockers             secretion of, 57–58       diagnosis of, 78–88
   1571   1572   1573   1574   1575   1576   1577   1578   1579   1580   1581